Drug intelligence / Profile preview

cyclopentolate (Denver Farma)

Development stage
Approved
Lead developer
Denver Farma
Modality
Small Molecules
Administration
Ophthalmic
01

Overview

AliviaMax is an ophthalmic solution containing cyclopentolate hydrochloride, a synthetic anticholinergic agent. Developed by Denver Farma, it is primarily used to induce mydriasis (dilation of the pupil) and cycloplegia (paralysis of the ciliary muscle) during diagnostic procedures such as refraction testing and ophthalmoscopic examinations. By competitively blocking muscarinic receptors in the eye, it prevents the contraction of the iris sphincter and the ciliary body muscle. It is typically available in 0.5% and 1% concentrations and is marketed in Argentina for ophthalmic use.

Brand names
AliviaMax
Other names
cyclopentolate hydrochlorideciclopentolato
02

Targets

CHRM3 (M3)CHRM2 (M2)M1 (Muscarinic acetylcholine receptor M1)

Beyond the preview

Go deeper on cyclopentolate (Denver Farma).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on cyclopentolate (Denver Farma).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call